Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Operating Expenses | 53,898 | 0 | 0 |
| Operating Income | -53,898 | N/A | N/A |
| Interest Expense | 381 | 0 | 0 |
| Other Income | 704 | 0 | 0 |
| Pre-tax Income | -53,575 | 0 | 0 |
| Net Income Continuous | -53,575 | N/A | N/A |
| Net Income | $-53,575 | $N/A | $N/A |
| EPS Basic Total Ops | -7.16 | N/A | N/A |
| EPS Basic Continuous Ops | -7.16 | N/A | N/A |
| EPS Diluted Total Ops | -7.16 | N/A | N/A |
| EPS Diluted Continuous Ops | -7.16 | N/A | N/A |
| EBITDA(a) | $-52,404 | $N/A | $N/A |